Evidence map›Paper›PMID 34507536›Full record

ArticleBMC cardiovascular disorders2021

Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study.

Arsene Zongo, Cerina Lee, Jason R B Dyck, Jihane El-Mourad, Elaine Hyshka, John G Hanlon, Dean T Eurich

Open access · goldAbstract read
In one paragraph

Article in BMC cardiovascular disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Arsene ZongoFaculty of Pharmacy, Université Laval, Quebec City, QC, Canada. arsene.zongo@pha.ulaval.ca.
Cerina LeeSchool of Public Health, University of Alberta, Edmonton, AB, Canada.
Jason R B DyckCardiovascular Research Centre, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
Jihane El-MouradFaculty of Pharmacy, Université Laval, Quebec City, QC, Canada.
Elaine HyshkaSchool of Public Health, University of Alberta, Edmonton, AB, Canada.
John G HanlonDepartment of Anesthesia, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
Dean T EurichSchool of Public Health, University of Alberta, Edmonton, AB, Canada.
University of Alberta · CAUniversité Laval · CAUniversity of Toronto · CA

Funding

CIHR PS 159668
6 · The paper itself

Abstract

backgroundCannabis is increasingly used for therapeutic purpose. However, its safety profile is not well known. This study assessed the risk of cardiovascular-related emergency department (ED) visit and hospitalization in adult patients authorized to use medical cannabis in Ontario, Canada from 2014 to 2017.

methodsThis is a longitudinal cohort study of patients who received medical cannabis authorization and followed-up in cannabis clinics, matched to population-based controls. The primary outcome was an ED visit or hospitalization for acute coronary syndrome (ACS) or stroke; and secondary outcome was for any cardiovascular event. Conditional Cox proportional hazards regression was used to assess the association between cannabis authorization and risk.

results18,653 cannabis patients were matched to 51,243 controls. During a median follow-up of 242 days, the incidence rates for ACS or stroke were 7.19/1000 person-years and 5.67/1000 person-years in the cannabis and controls group, respectively- adjusted hazard ratio (aHR) of 1.44 (95% CI 1.08-1.93). When stratified by sex, the association was only statistically significant among males: aHR 1.77 (1.23-2.56). For the secondary outcome (any CV events), the aHR was 1.47 (1.26-1.72). The aHR among males and females were 1.52 (1.24-1.86) and 1.41 (1.11-1.79), respectively. Tested interaction between cannabis authorization and sex was not significant (p > 0.05).

conclusionsMedical cannabis authorization was associated with an increased risk of ED visits or hospitalization for CV events including stroke and ACS.

Indexed as

Acute Coronary SyndromeAdultAgedAged, 80 and overAge FactorsCardiovascular DiseasesEmergency Service, HospitalFemaleHospitalizationHumansLongitudinal StudiesMaleMedical MarijuanaMiddle AgedOntarioPrognosisMedical MarijuanaAcute coronary syndromeCardiovascular eventsEmergency department visitHospitalizationLongitudinal cohort studyMedical cannabisStroke

Identifiers

PMID34507536
PMCPMC8431905
OpenAlexW3169486157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.